Unraveling Targets of Therapy in Bronchial Thermoplasty in Severe Asthma (TASMA) Extension Study

TASMA Extension Study: Long Term Efficacy and Safety of Bronchial Thermoplasty in Severe

This study evaluates the longterm clinical outcomes, including safety and efficacy parameters after Bronchial Thermoplasty (BT) treatment over a period of 5 years. All patients included in de TASMA trial in the Netherlands will be asked to participate in the TASMA extension study.

Inclusion Criteria:

• Subject participation in the TASMA study
• Ability and willingness to provide informed consent.
• Ability to comply with the study protocol

Exclusion Criteria:

• Subject participating in another clinical trial involving respiratory intervention which in the opinion of the investigator might interfere with the study.